Integrated Animal Health Initiates Multiple US Trials and Announces Key Appointment

By August 12, 2016Uncategorized



Contact: Dr Blake Hawley: 785-260-1094

Lawrence, Kan., 9 Aug, 2016 – Integrated Animal Health (IAH), a global company focused on identifying and commercializing new-to-the-world animal health solutions, announced initiation of six separate research trials.

It is also announcing today that Dr Tom Hemling, formerly Global Head of R&D at De Laval, has joined the company as its Director of Research on a consulting basis. Dr Hemling is one of the world’s foremost experts on dairy and has dozens of papers to his credit on a wide variety of dairy related issues.

Dr Blake Hawley, IAH President and CEO, said, “We are very pleased to have Tom join us. His wealth of knowledge and experience is a phenomenal asset for us, and his global contacts are, arguably, unparalleled in the dairy industry. I have known Tom for quite some time now and he is a tremendous at helping IAH evaluate new technologies, intellectual property and patent strength.”

Dr Hemling commented, “I have spent the past 24 years working on innovation in prevention of disease in food producing animals. With the current increased pressure to reduce the use of antibiotics in animals, the need for novel approaches to maintain animal welfare is even greater. Innovations will likely occur in better preventative products and methods, improved nutritional management, and both innate and adaptive immune stimulation. These approaches will help lessen the demand for antibiotics, and help meet consumer demands for more organic food production. Integrated Animal Health is focusing on developing these technologies and delivering the data packages to bring these to market. I am happy to help the IAH team find and develop these transformative, novel technologies.”

In other news, IAH is now progressing multiple trials with multiple species and partners.


Product/Technology Species Indication
Scour-Mate™ Calves Acute Diarrhea
Scour-Mate™ + Repellion™ Dairy Calves Fly & Scour Prevention
Crave-It™ Foods w/Repellion™ Deer Tick &Fly Prevention
Medicated Food Dogs Ectoparasiticides
Repellion™ Hogs Wt Gain/Fly Prevention
IAH-530 Cattle Bovine Respiratory Disease


“We are excited to accelerate some of our top product candidates through these trials. We are developing solid, field and clinical data to demonstrate efficacy. Developing these ground-breaking technologies including a line of natural, nutritional products, will substantially add to our existing suite of products,” said Dr. Blake Hawley.

IAH has taken five products to market in very short periods compared to traditional animal health companies by conducting early commercial proof of concept studies. Headquartered at the Bioscience & Technology Business Center outside the Kansas University Campus in Lawrence, Kan., the company has strong ties to the Animal Health Corridor and plans to perform its FDA CVM trials for its prescription products in the Midwest.

IAH has a corporate mission that all products must fit into the existing workflow of farmer and ranchers or meet the lifestyle demands of pet owners.

“No matter how innovative the technology appears, if you can’t use it on the farm with ease, we don’t want to struggle commercializing it. We look for breakthrough technologies that deliver results, both in the animal and for those who deliver it,” Dr. Hawley said.

About Integrated Animal Health

Integrated Animal Health (IAH) provides multiple pathways to market for products that aim to disrupt current paradigms for the use of antibiotics, pesticides and novel animal drugs, biologics and cancer therapies used in animals. With world headquarters in the heart of the Animal Health Corridor, IAH is the new engine driving innovation in animal health by helping companies bring transformative solutions to market. Its technologies target significant and costly issues in production animal systems, such as mastitis, diarrhea and insect control to help companies satisfy consumer demand for sustainable, natural, antibiotic-free, and pesticide-free products while meeting the demand for growth. Offering a deep and fertile pipeline of more than 30 pioneering technology platforms, IAH is advancing its pipeline to include a wide range of applications, including products targeting equine and companion animal markets. The company has offices in the US, Australia, Europe and New Zealand. For more information, visit


# # #